These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27272175)

  • 1. The effect of lymphadenectomy on survival and recurrence in patients with ovarian cancer: a systematic review and meta-analysis.
    Zhou J; Shan G; Chen Y
    Jpn J Clin Oncol; 2016 Aug; 46(8):718-26. PubMed ID: 27272175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on lymphadenectomy in early and advanced ovarian cancer.
    Angioli R; Plotti F; Palaia I; Calcagno M; Montera R; Cafà EV; Sereni MI; Panici PB
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):34-9. PubMed ID: 18197003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic aortic and pelvic lymphadenectomy versus resection of bulky nodes only in optimally debulked advanced ovarian cancer: a randomized clinical trial.
    Panici PB; Maggioni A; Hacker N; Landoni F; Ackermann S; Campagnutta E; Tamussino K; Winter R; Pellegrino A; Greggi S; Angioli R; Manci N; Scambia G; Dell'Anna T; Fossati R; Floriani I; Rossi RS; Grassi R; Favalli G; Raspagliesi F; Giannarelli D; Martella L; Mangioni C
    J Natl Cancer Inst; 2005 Apr; 97(8):560-6. PubMed ID: 15840878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of lymphadenectomy on survival after recurrence in patients with advanced ovarian cancer without suspected lymph node metastasis.
    Paik ES; Shim M; Choi HJ; Lee YY; Kim TJ; Lee JW; Kim BG; Bae DS; Choi CH
    Gynecol Oncol; 2016 Nov; 143(2):252-257. PubMed ID: 27567053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic lymphadenectomy in the treatment of epithelial ovarian cancer: a meta-analysis of multiple epidemiology studies.
    Gao J; Yang X; Zhang Y
    Jpn J Clin Oncol; 2015 Jan; 45(1):49-60. PubMed ID: 25387732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic pelvic and aortic lymphadenectomy in advanced ovarian cancer patients at the time of interval debulking surgery: a double-institution case-control study.
    Fagotti A; De Iaco P; Fanfani F; Vizzielli G; Perelli F; Pozzati F; Perrone AM; Turco LC; Scambia G
    Ann Surg Oncol; 2012 Oct; 19(11):3522-7. PubMed ID: 22644507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Pelvic and Para-aortic Lymphadenectomy in Advanced Ovarian Cancer After Neoadjuvant Chemotherapy.
    Schwartz L; Schrot-Sanyan S; Brigand C; Baldauf JJ; Wattiez A; Akladios C
    Anticancer Res; 2015 Oct; 35(10):5503-9. PubMed ID: 26408716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node-positive stage IIIC ovarian cancer: a separate entity?
    Berek JS
    Int J Gynecol Cancer; 2009 Dec; 19 Suppl 2():S18-20. PubMed ID: 19955908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of systematic pelvic and para-aortic lymphadenectomy in the management of patients with advanced epithelial ovarian, tubal, and peritoneal cancer: A systematic review and meta-analysis.
    Tzanis AA; Antoniou SA; Zacharoulis D; Ntafopoulos K; Tsouvali H; Daponte A
    Eur J Obstet Gynecol Reprod Biol; 2023 Jun; 285():198-203. PubMed ID: 37149928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic para-aortic and pelvic lymphadenectomy in early stage epithelial ovarian cancer: a prospective study.
    Ditto A; Martinelli F; Reato C; Kusamura S; Solima E; Fontanelli R; Haeusler E; Raspagliesi F
    Ann Surg Oncol; 2012 Nov; 19(12):3849-55. PubMed ID: 22707110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retroperitoneal lymphadenectomy and survival of patients treated for an advanced ovarian cancer: the CARACO trial].
    Classe JM; Cerato E; Boursier C; Dauplat J; Pomel C; Villet R; Cuisenier J; Lorimier G; Rodier JF; Mathevet P; Houvenaeghel G; Leveque J; Lécuru F
    J Gynecol Obstet Biol Reprod (Paris); 2011 May; 40(3):201-4. PubMed ID: 21482037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of systematic lymphadenectomy during debulking surgery in the treatment of ovarian cancer: a meta-analysis of randomized controlled trials.
    Lin Q; Liu W; Xu S; Li J; Tong J
    J Ovarian Res; 2020 May; 13(1):56. PubMed ID: 32384898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study.
    Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N
    J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
    Aletti GD; Dowdy S; Podratz KC; Cliby WA
    Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival benefits of para-aortic lymphadenectomy in colorectal cancer with clinically suspected para-aortic lymph node metastasis: a meta-analysis and systematic review.
    Wang RC; Wang JQ; Zhou XY; Zhong CL; Chen JX; Chen JS
    World J Surg Oncol; 2023 Jan; 21(1):28. PubMed ID: 36721235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of pelvic and para-aortic node metastases in early-stage ovarian cancer.
    Bachmann C; Krämer B; Brucker SY; Stäbler A; Fend F; Wallwiener D; Grischke EM; Rothmund R
    Anticancer Res; 2014 Nov; 34(11):6735-8. PubMed ID: 25368283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery.
    Eoh KJ; Lee JY; Yoon JW; Nam EJ; Kim S; Kim SW; Kim YT
    Oncotarget; 2017 Jun; 8(23):37807-37816. PubMed ID: 27906676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphadenectomy in clinically early epithelial ovarian cancer and survival analysis (LILAC): a Gynecologic Oncology Research Investigators Collaboration (GORILLA-3002) retrospective study.
    Yang EJ; Lee AJ; Hwang WY; Chang SJ; Kim HS; Kim NK; Kim Y; Kong TW; Lee EJ; Park SJ; Son JH; Suh DH; Son DH; Shim SH
    J Gynecol Oncol; 2024 Jul; 35(4):e75. PubMed ID: 38497109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of lymph node involvement or lymphadenectomy on prognosis of patients with borderline ovarian tumors: A systematic review and meta-analysis.
    Fan Y; Zhang YF; Wang MY; Mu Y; Mo SP; Li JK
    Gynecol Oncol; 2021 Sep; 162(3):797-803. PubMed ID: 34119365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis.
    Chiyoda T; Sakurai M; Satoh T; Nagase S; Mikami M; Katabuchi H; Aoki D
    J Gynecol Oncol; 2020 Sep; 31(5):e67. PubMed ID: 32808497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.